Summary
- Current Price
- As of today, VTRS price is $14.93, down -2.10% on
- Current Price All-Time High
- VTRS price is currently -80.53% below its historical high of $76.69 set on
- Market Cap
- VTRS current market cap is $17B, up +56.44% over the past 365 days
- PE Ratio
- VTRS PE ratio is unknown
- Revenue
- VTRS current annual revenue is $14.30B, down -2.79% year-over-year
- Next Earnings
- The next earnings release for VTRS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Viatris Inc. |
| Ticker | NASDAQ: VTRS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | viatris.com |
| Employees | 32,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $14.93 | |
| Price, 1D Change | -2.10% | |
| Market Cap | $17B | |
| TTM Dividend Yield | 3.22% | |
| PE Ratio | - | |
| Beta | 0.88 | |
| Revenue | $14B | |
| Revenue, 1Y Change | -2.79% | |
| EPS | -$3.00 | |
| EPS, 1Y Change | -464.89% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.12 | |
| Next Ex-Dividend | $0.12 | |
| Last Split | 3:2 | |
| Next Split | N/A | N/A |
| Last Ticker Change | VTRSV | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$3.00 | |
| EPS Estimate | N/A | $2.44 |
| EPS Est. Change | N/A | +181.31% |
| Revenue | $14.30B | |
| Revenue Estimate | N/A | $14.57B |
| Revenue Est. Change | N/A | +1.92% |
| Current Price | $14.93 | |
| Price Target | - | $15.00 |
| Price Tgt. Change | - | +0.47% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.68 | -$0.53 | -119.82% | |
| $2.31 | -$3.00 | -229.96% | |
| $2.44 | N/A | +181.31% | |
| $2.67 | N/A | +188.90% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $14.82B | $14.71B | -0.73% | |
| $14.12B | $14.30B | +1.25% | |
| $14.57B | N/A | +1.92% | |
| $14.83B | N/A | +3.71% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +61.76% | |
| Price, 3Y | +34.14% | |
| Market Cap, 1Y | +56.44% | |
| Market Cap, 3Y | +29.40% | |
| Revenue, 1Y | -2.79% | |
| Revenue, 3Y | -11.58% | |
| EPS, 1Y | -464.89% | |
| EPS, 3Y | -275.85% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $14.93 | |
| SMA 200 | $10.76 | |
| SMA 200 vs Price | -27.91% | |
| SMA 50 | $13.65 | |
| SMA 50 vs Price | -8.60% | |
| Beta | 0.88 | |
| ATR | $0.48 | |
| 14-Day RSI | 51.78 | |
| 10-Day Volatility | 30.38% | |
| 1-Year Volatility | 34.05% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.12 | |
| Upcoming | $0.12 | |
| Dividend Yield | 3.22% | |
| Total Dividend | $0.48 | |
| $561.20M | ||
| -15.97% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $14.30B | |
| EPS | -$3.00 | |
| Gross Profit | $5.08B | |
| Gross Margin | 35.53% | |
| Operating Profit | $423.50M | |
| Operating Margin | 2.96% | |
| Net Income | -$3.51B | |
| Net Margin | -24.58% | |
| EBITDA | $3.22B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.98 | |
| 1.38 | ||
| 0.82 | ||
| - | ||
| 5 | ||
| 0.95 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| 1.21 | ||
| 1.17 | ||
| 8.60 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $14.71B | |
| $1.32B | ||
| $37.19B | ||
| $9.79B | ||
| $22.48B | ||
| $7.09B | ||
| Total Debt | $14.41B | |
| $1.93B | ||
| $1.29B |
Expenses
| Metric | Date | Value |
|---|---|---|
| $17.81B | ||
| $4.66B | ||
| $9.22B | ||
| $0.00 | ||
| $2.72B | ||
| $0.00 | ||
| -$150.10M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $2.32B | ||
| -$427.70M | ||
| -$1.29B | ||
| Capex | $465.10M | |
| $1.85B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | → | |
| Argus Research | → | |
| Barclays | ||
| Truist Securities | ||
| Goldman Sachs | ||
| Jefferies | → | |
| Piper Sandler | → | |
| B of A Securities | → | |
| Barclays | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with VTRS
FAQ
What is the ticker symbol for Viatris Inc.?
The ticker symbol for Viatris Inc. is NASDAQ:VTRS
Does Viatris Inc. pay dividends?
Yes, Viatris Inc. pays dividends. The last payment was $0.12, with an ex-dividend date on November 23, 2025
What sector is Viatris Inc. in?
Viatris Inc. is in the Healthcare sector
What industry is Viatris Inc. in?
Viatris Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Viatris Inc. based in?
Viatris Inc. is headquartered in United States
When did Viatris Inc. go public?
Viatris Inc. initial public offering (IPO) was on March 17, 1980
Is Viatris Inc. in the S&P 500?
Yes, Viatris Inc. is included in the S&P 500 index
Is Viatris Inc. in the NASDAQ 100?
No, Viatris Inc. is not included in the NASDAQ 100 index
Is Viatris Inc. in the Dow Jones?
No, Viatris Inc. is not included in the Dow Jones index
When was Viatris Inc. last earnings report?
Viatris Inc.'s most recent earnings report was on February 26, 2026
When does Viatris Inc. report earnings?
The next expected earnings date for Viatris Inc. is May 7, 2026
Data Sources & References
- VTRS Official Website www.viatris.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1792044/000179204426000013/0001792044-26-000013-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1792044/000179204426000013/0001792044-26-000013-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- VTRS Profile on Yahoo Finance finance.yahoo.com/quote/VTRS
- VTRS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vtrs